Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid

The Journal of Pediatrics

Volumn 108, Issue 6, 1986, Pages 997-1004

  Jäger Roman, Elke ^a   Deichl, Alfons ^a   Jakob, Susanne ^a   Hartmann, Anna Maria ^a   Koch, Sabine ^a   Rating, Dietz ^a   Steldinger, Rainer ^a   Nau, Heinz ^a   Helge, Hans ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHOSUXIMIDE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ADVERSE DRUG REACTION; APGAR SCORE; BONE; BRACHYCEPHALY; CENTRAL NERVOUS SYSTEM; CHEMICAL TERATOGENESIS; CLINICAL ARTICLE; CONGENITAL DISORDER; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG THERAPY; EMBRYO; EPILEPSY; FETUS; FETUS DISTRESS; FETUS GROWTH; FINGER MALFORMATION; HUMAN; MATERNAL DISEASE; NEWBORN; ORAL DRUG ADMINISTRATION; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; THERAPY;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; EPILEPSY; FEMALE; FETUS; GROWTH; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; VALPROIC ACID;

EID: 0022635244     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(86)80949-0     Document Type: Article

References (27)

1. Teratogenicity of valproic acid
2. Possible teratogenicity of valproic acid
3. Teratogenic effects of anticonvulsants
4. Possible teratogenic effect of valproic acid
5. Possible teratogenic effect of valproate during pregnancy
6. Valproic acid and fetal abnormality
7. The fetal valproate syndrome
8. Antiepileptika während der Schwangerschaft
9. Das soziale Selbstbild der Gesellschaftsschichten in Deutschland
10. Epidemiologie und Klassifikation von Epilepsien und epileptischen Anfällen
11. Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites
12. Clinical assessment of gestational age in the newborn infant
13. Intrauterine growth of live born caucasian infants at sea level. Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation
14. Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero
15. Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women
16. Fetal head growth retardation associated with maternal antiepileptic drugs
17. Current status of teratology
18. Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy
19. Concentrations of free fatty acids in maternal and umbilical cord blood during effective caesarian section
20. The pattern of blood lipids, glycerol and ketone bodies during the neonatal period, infancy and childhood
21. Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsansts and free fatty acids
22. Valproic acid dosage and plasma protein binding and clearance
23. A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations
24. Embryotoxicity testing of valproic acid
25. Maternal valproic acid and congenital neural tube defects
26. Risk to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome
27. The fetal trimethadione syndrome